High out‑of‑pocket spending and financial hardship at the end of life among cancer survivors and their families.

"Declarations Ethics approval and consent to participateNot applicable. Consent for publicationNot applicable. Competing interestsMs. Jingxuan Zhao has received grant/research support from AstraZeneca outside the scope of this study. Dr. K. Robin Yabroff serves on the Flatiron Health Equity Advisory Board. Ms. Jingxuan Zhao and Dr. K. Robin Yabroff are employed by the American Cancer Society, which receives grants from private and corporate foundations, including foundations associated with companies in the health sector for research. Competing interests Ms. Jingxuan Zhao has received grant/research support from AstraZeneca outside the scope of this study. Dr. K. Robin Yabroff serves on the Flatiron Health Equity Advisory Board. Ms. Jingxuan Zhao and Dr. K. Robin Yabroff are employed by the American Cancer Society, which receives grants from private and corporate foundations, including foundations associated with companies in the health sector for research."

"Funding No specific funding has been received for this commentary."